Evidence map›Paper›PMID 36032234›Full record

SynthesisFrontiers in psychiatry2022

Post-COVID-19 fatigue: A systematic review.

Jian Joli, Patrizia Buck, Stephan Zipfel, Andreas Stengel

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05813613 (Role of Artificial Intelligence in Predicting Muscle Fatigue Using Virtual Reality Training In Healthy And Post COVID19 Subjects), which is not on this map. Cited by 85 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05813613 completednot on this mapstarted 2023, after this paper: background citation

Role of Artificial Intelligence in Predicting Muscle Fatigue Using Virtual Reality Training In Healthy And Post COVID19 Subjects

TypeobservationalSponsorBeirut Arab UniversityRan2023 to 2023Enrolled90ConditionsFatigueArmsSquatting with the aid of Kynapsis Virtual Training apparatus.
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO International Clinical Trials Platform.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Post-COVID Rehabilitation Outcomes: A Comparative Cohort Study.Archives of rehabilitation research and clinical translation · 2025
    Article
  18. Review
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jian JoliDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.
Patrizia BuckDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.
Stephan ZipfelDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.
Andreas StengelDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2. This systematic review was performed to describe symptoms, etiology, possible risk factors related to post-COVID-19 fatigue and the therapeutic approaches used for the treatment of post-COVID-19 fatigue. For the systematic literature search the databases PubMed, Web of Science, Cochrane Library, and PsycInfo were used. All articles that met the inclusion criteria were analyzed for demographics, clinical data and treatment. Included were studies which focused on an adult population (18-65 years old); elderly patients and patients with chronic somatic diseases which can also cause fatigue were excluded. We identified 2,851, screened 2,193 and finally included 20 studies with moderate to high methodological quality, encompassing 5,629 participants. Potential risk factors for post-COVID-19 fatigue were old age, female sex, severe clinical status in the acute phase of infection, a high number of comorbidities, and a prediagnosis of depression/anxiety. Lastly, a possible autoimmune etiology was suspected. Several treatment approaches have been tested mostly in small and uncontrolled studies so far: a Chinese herbal formulation improved breathlessness and fatigue. Moreover, molecular hydrogen (H Systematic Review Registration: Unique Identifier: CRD42022320676, https://www.crd.york.ac.uk/PROSPERO/.

Indexed as

brain fogCOVID-19etiologylong-COVIDpost-COVID fatiguepsychosomaticsymptomstherapy

Identifiers

PMID36032234
PMCPMC9403611

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.